establishing safety and care requirements for clinician-administered drugs.

Latest action: Executive Session: 10/14/2026 10:00 am GP 229

Voted 10/1/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

10/1/2026Executive Session: 10/14/2026 10:00 am GP 229
9/17/2026Subcommittee Work Session: 10/07/2026 10:00 am GP 229
8/21/2026Subcommittee Work Session: 09/09/2026 10:00 am GP 229
5/14/2026Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2
5/1/2026Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6
4/22/2026Executive Session: 04/29/2026 10:00 am GP 229
4/16/2026Subcommittee Work Session: 04/22/2026 10:00 am GP 229
4/2/2026Public Hearing: 04/07/2026 02:15 pm GP 159
4/1/2026Subcommittee Work Session: 04/08/2026 10:00 am GP 229
3/2/2026Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127